Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

IsraelRecruiting

Conditions

Refractory Angina

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Contact: Study coordinator (Shmuel Banai, Prof.) · 972-3-6973395
Contact: Study coordinator (Gad Keren, Prof.) · 972-3-6974762
Tel Aviv Medical Center, Tel Aviv, Israel
Contact: Study coordinator (Shmuel Banai, Prof) · shmuelb@tlvmc.gov.il · 972-3-6973395

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction.

Refractory Angina · Microvascular Angina · Microvascular Coronary Artery Disease

Abroad (travel likely)Recruiting

London, United Kingdom

COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina

Coronary Microvascular Disease · Refractory Angina

Abroad (travel likely)Recruiting

Mainz, Germany

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II

Refractory Angina

Abroad (travel likely)Recruiting

Phoenix, United States · Scottsdale, United States

Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina

Refractory Angina Pectoris · Refractory Angina

Abroad (travel likely)RecruitingPHASE2

London, United Kingdom